TherapeuticsMD (TXMD) Other financing activities (2010 - 2026)

TherapeuticsMD has reported Other financing activities for 12 years, with the latest figure at $2000.0 in Q1 2026.

• For the quarter ending Q1 2026, Other financing activities fell 91.3% year-over-year to $2000.0; the trailing twelve-month figure through Mar 2026 stood at $1.4 million (up 372.15% YoY), and the FY2023 full-year result was $1.3 million, down 21.64% from the prior year.
• Other financing activities for Q1 2026 stood at $2000.0, down from $23000.0 in the prior quarter.
• The five-year high for Other financing activities was $1.3 million in Q4 2023, with the low at -$1.1 million in Q3 2023.
• Historically, Other financing activities has averaged $336555.6 across 5 years, with a median of $111000.0 in 2024.
• The largest YoY upside for Other financing activities was 42.33% in 2023 against a maximum downside of 251.85% in 2023.
• TherapeuticsMD's Other financing activities stood at $893000.0 in 2022, then surged by 42.33% to $1.3 million in 2023, then tumbled by 91.27% to $111000.0 in 2024, then slumped by 79.28% to $23000.0 in 2025, then slumped by 91.3% to $2000.0 in 2026.
• The last three Other financing activities figures came in at $2000.0 (Q1 2026), $23000.0 (Q1 2025), and $111000.0 (Q1 2024), per Business Quant data.